Unbiased News Awaits.
Published loading...Updated

High Times for German Cannabis Firm Amid Medical Boom

  • A Berlin-based pharmaceutical company called Cantourage produces and distributes cannabis-based medicinal products in Germany as of 2025.
  • Partial legalisation of cannabis last year, allowing possession of up to 25 grams and growing three plants per household, increased public access and awareness.
  • Cantourage's facility in Bavaria secures large amounts of imported cannabis from Jamaica, Uganda, and New Zealand, with staff following strict safety protocols.
  • In December 2024, the number of cannabis prescriptions dispensed by pharmacies rose dramatically compared to March 2024, resulting in the company’s revenue increasing by 118 percent to reach 51.4 million euros for the year.
  • Despite political opposition and a planned open-ended review by Chancellor Merz’s coalition government, Cantourage expects its business model to remain viable regardless of regulatory changes.
Insights by Ground AI
Does this summary seem wrong?

72 Articles

All
Left
9
Center
15
Right
12
charitonleader.comcharitonleader.com
+68 Reposted by 68 other sources
Center

High times for German cannabis firm amid medical boom

At an undisclosed site in Germany's Bavaria state, pharmaceutical CEO Philip Schetter opens a 75-centimetre (30-inch) thick steel door that secures his wares: vast amounts of cannabis.

·Chariton, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 42% of the sources are Center
42% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

KULR-TV broke the news in Billings, United States on Sunday, May 18, 2025.
Sources are mostly out of (0)